1. Home
  2. NTIC vs OKYO Comparison

NTIC vs OKYO Comparison

Compare NTIC & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$7.75

Market Cap

75.1M

Sector

Industrials

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.33

Market Cap

71.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTIC
OKYO
Founded
1970
2007
Country
United States
United Kingdom
Employees
94
5
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.1M
71.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NTIC
OKYO
Price
$7.75
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
11.0K
79.3K
Earning Date
04-09-2026
07-18-2025
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$84,234,474.00
N/A
Revenue This Year
$12.49
N/A
Revenue Next Year
$7.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.35
$1.28
52 Week High
$10.03
$3.20

Technical Indicators

Market Signals
Indicator
NTIC
OKYO
Relative Strength Index (RSI) 49.91 40.81
Support Level $7.88 $1.31
Resistance Level $8.09 $1.72
Average True Range (ATR) 0.19 0.10
MACD 0.00 -0.01
Stochastic Oscillator 66.67 26.47

Price Performance

Historical Comparison
NTIC
OKYO

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

Share on Social Networks: